Prospective validation and extension of the multimodality prognostic score for the treatment allocation of pleural mesothelioma patients
This is where things get specific, and where people often make mistakes by self-selecting out of a claim they actually have
Indications for use: The medication states that it should be used in combination with diet and physical activity
Contemp Clin Trials (2015) 45:13945
Add Membership for $19.95 OR Spend $150 and get Free Membership added to cart
Lillys tirzepatide shows additional 21.1% weight loss after weeks of intensive lifestyle intervention, for a total mean loss of 26.6% from study entry over 84 weeks, Eli Lilly (2023) Tirzepatide for the treatment of adults with Type 2 diabetes: An endocrine perspective, Diabetes, Obesity and Metabolism (2022) Tirzepatide once weekly for the treatment of obesity, The New England Journal of Medicine (2022) Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial, Nature Medicine (2023) Acute pancreatitis during GLP-1 receptor agonist treatment
